10 | $HOUR get S@2.8 and now PMH@>4 | znewcar1 | 12/26/2024 9:13:25 AM |
9 | $HOUR 51% v33,4M c2.39 f35,047M H4.89 ML1.41=LL | znewcar1 | 05/02/2023 4:18:48 PM |
8 | HOUR 9% v2,4M c3.81 f35M H4.13 | znewcar1 | 04/05/2022 11:51:15 PM |
7 | HOUR 14% v2,3M c3.49 f35,0M H3.58 ML1.88 MH6.2 | znewcar1 | 04/04/2022 4:51:34 PM |
6 | HOD6.2 @4.87 LOD 20dma@3 to dip | znewcar1 | 03/21/2022 11:02:58 AM |
5 | HOUR 29% v4,6M c4.57 f35M | znewcar1 | 03/17/2022 6:47:50 PM |
4 | HOUR 31% v14,5M c3.99 f35M H5.000 afternoon bull | znewcar1 | 03/15/2022 5:50:28 PM |
3 | HOUR 20% v948M c3.04 f35M H3.160 S@2.6 | znewcar1 | 03/14/2022 4:22:34 PM |
2 | HOUR 28% v6,6M c2.63 f35M | znewcar1 | 03/09/2022 9:21:37 PM |
1 | HOUR 21% v1,7M c3.29 f35M H3.37 Haft | znewcar1 | 03/03/2022 6:02:32 PM |
Recent Articles
- Steve Eisman's Take on Opendoor's Soaring Stock Price
- Akeso's Ivonescimab Receives NMPA Approval for Lung Cancer Treatment
- Revolutionizing Pet Eye Care: Dômes Pharma and Fear Free Unite
- Samsung's Bold $16.5 Billion Chip Deal to Compete in Tech Sector
- Exploring the Success of CBD Fair Guangzhou's 2025 Edition
- Economic Impact of Trump's Trade Deal: What Comes Next?
- Antengene Prepares for Major Presentation on ATG-022 at ESMO
- How Japan's $550 Billion Deal Can Boost TSMC's Growth in the US
- Hengrui Pharma and GSK Forge Agreement for Advanced Drug Development
- Time Is Running Out for Solar Tax Credit Savings with All Energy Solar
- US and China Seek Trade Solutions Amid Tariff Tensions
- Introducing Automate's Push PRO: Revolutionary Shade Control
- Exciting Esports World Cup Promotion from JBO Thailand
- Harbour BioMed Unveils Strong Profit Predictions for Future Growth
- Ascletis Begins Significant Obesity Study with ASC30 Drug
- Elpis Biopharmaceuticals Partners with NCCS for Groundbreaking Research
- Perseus Mining's Operational Highlights and Financial Overview
- Shara Magomedov Shines at UFC Night with Epic Victory
- Investors Urged to Participate in Class Action Against Centene
- Exploring America’s Hidden Resource Potential and Technology
- Trump's New Tariff Deal with EU: Impacts and Insights
- Shaquille O'Neal's Hilarious Showdown with Jimmy Kimmel
- Empowering Hims & Hers Health Shareholders: Your Legal Guide
- Public Sentiment on Trump's Tax Cuts: A Closer Look
- Innovative Cooling Solutions Pioneered by i2Cool for a Sustainable Future
- Easterly ROCMuni Fund Class Action: Investor Rights Explained
- Class Action Alert: RxSight Investors Take Action Against Losses
- Investors of iRobot Corporation Urged to Act Before Deadline
- Dustin Moskovitz Expands Asana Holdings with Major Purchase
- Navigating High-Stress Careers: Insights from Executives
- Banco Comercial Português Updates on Share Buy-Back Programme Activity
- Centene Corporation Faces Class Action Over Investor Losses
- Banco Comercial Português (BCP) Shares Buy-Back Program Update
- Insights into Gilead Sciences, Inc. and Recent Developments
- Legal Action Initiated Against Flywire Corporation's Officers
- Replimune Group Faces Legal Action Amid Stock Price Decline
- Investors Seek Clarity on Simulations Plus Financial Concerns
- Shocking Survey: How Much Would You Sacrifice For Wealth?
- Harnessing Natural Testosterone Boosters for Optimal Muscle Growth
- Neuralink’s Recent Developments and Future Aspirations Explained
- Global AI Cooperation: China's Vision for the Future of Technology
- Investment Insights from Experts: Maximize Your $10,000 Now
- Shiba Inu's 3,000% Growth Potential in Competitive Memecoin Market
- Investors Seek Justice in Biohaven Ltd. Class Action Lawsuit
- Class Action Lawsuit Against Hims & Hers Health, Inc. Explained
- Sarepta Therapeutics Faces Legal Challenges Amidst Controversies
- Investors Take Note: Class Actions Against Western Asset Management
- Mereo BioPharma Faces Scrutiny as Investigation Unfolds
- Centene Corporation Faces Class Action Lawsuit Amidst Losses
- Investigation Unfolds for Capricor Therapeutics Amid Stock Fluctuations